Individualized Cardiac Index–Guided Hemodynamic Therapy in High-Risk Patients Undergoing Elective Major Abdominal Surgery
Source: View publication →
In high-risk patients undergoing elective major abdominal surgery, individualized goal-directed hemodynamic therapy targeting the patient's preoperative resting cardiac index did not significantly reduce the 7-day incidence of a composite of major organ injury, severe infection, or death compared with routine hemodynamic therapy.
Key Findings
Study Design
Study Limitations
Clinical Significance
The results of this trial do not support the routine use of individualized cardiac index-guided hemodynamic optimization over standard intraoperative care in high-risk patients undergoing major abdominal surgery. The findings demonstrate the general adequacy of modern routine perioperative hemodynamic management and suggest that introducing more complex, individualized monitoring protocols for specific cardiac index targets does not yield short-term clinical outcome benefits in this population.
Historical Context
Goal-directed hemodynamic therapy (GDHT) has been a heavily debated concept in perioperative medicine for decades, historically pioneered by Shoemaker to maximize oxygen delivery and minimize tissue hypoperfusion. While earlier, smaller trials suggested that GDHT could substantially reduce postoperative complications and mortality in high-risk surgical patients, recent large-scale, pragmatic, multicenter randomized controlled trials (such as OPTIMISE and OPTIMISE II) have increasingly demonstrated null results when comparing algorithm-based hemodynamic therapy to modern routine care. The PELICAN trial builds upon this ongoing debate by evaluating a highly tailored approach—targeting each patient's specific preoperative resting cardiac index rather than an arbitrary, 'one-size-fits-all' standard—yet it reinforces the emerging consensus that protocolized hemodynamic interventions do not incrementally improve composite outcomes over contemporary standard anesthetic care.
Guided Discussion
High-yield insights from every perspective
What are the physiological determinants of Cardiac Index (CI), and why was matching a patient's preoperative resting CI during surgery theoretically hypothesized to prevent postoperative organ injury?
Key Response
CI is cardiac output (heart rate multiplied by stroke volume) normalized to body surface area. Surgery induces a hypermetabolic state and systemic stress; the hypothesis was that failing to maintain a patient's unique baseline perfusion (their individualized resting CI) would lead to an oxygen supply-demand mismatch, resulting in tissue hypoxia, anaerobic metabolism, and subsequent acute organ dysfunction such as acute kidney or myocardial injury.
In the operating room setting, if an individualized CI-guided protocol dictates that a patient's intraoperative cardiac index is falling significantly below their target, what are the stepwise pharmacological and fluid management strategies utilized to restore it?
Key Response
Management typically begins with assessing fluid responsiveness using dynamic parameters like stroke volume variation or pulse pressure variation to administer crystalloids or colloids. If preload is optimized but CI remains low, providers use inotropes (e.g., dobutamine) to increase contractility, or adjust vasopressors (e.g., norepinephrine) to ensure adequate perfusion pressure while balancing afterload.
Early goal-directed hemodynamic therapy (GDHT) trials showed significant outcome benefits, yet this contemporary trial of individualized CI-guided therapy showed no benefit over routine care. What modern perioperative shifts explain this attenuation of benefit?
Key Response
Modern 'routine' care has evolved dramatically, universally incorporating Enhanced Recovery After Surgery (ERAS) protocols, balanced restrictive fluid strategies, and better baseline monitoring. Consequently, the delta in actual hemodynamic management between the intervention and standard-of-care arms is much smaller today. Furthermore, targeting a 'resting' preoperative CI may physiologically underestimate the hyperdynamic requirements of surgical stress.
Given that individualized, semi-invasive cardiac index monitoring did not improve the 7-day composite outcomes in high-risk abdominal cases, how should this evidence drive changes in departmental intraoperative resource allocation and standard operating procedures?
Key Response
This trial supports moving away from the routine, resource-intensive deployment of individualized CI monitoring and the associated overtreatment risks (like excessive inotrope use). Instead, departments should allocate resources toward standardizing high-quality routine hemodynamic care, such as non-invasive goal-directed fluid therapy based on dynamic parameters, which is equally effective and less costly.
Scholarly Review
Critical appraisal through the lens of expert reviewers and guideline development
The trial utilized a 7-day composite outcome of major organ injury, severe infection, or death. What are the methodological vulnerabilities of using this specific composite in an intraoperative hemodynamic trial, and how might it dilute the observable treatment effect?
Key Response
Composite outcomes increase statistical power but assume all components are equally responsive to the intervention. Hemodynamic interventions most directly mediate end-organ perfusion (impacting acute kidney or myocardial injury), whereas severe infections might be driven primarily by surgical technique, bowel prep, or antibiotic timing. Including less biologically plausible components dilutes the effect size and biases results toward the null.
When assessing the internal validity of this unblinded hemodynamic trial, what specific data points regarding protocol adherence in the intervention arm and crossover/co-intervention in the control arm are most critical to scrutinize?
Key Response
In unblinded pragmatic trials, control arm contamination (anesthesia providers intuitively utilizing GDHT principles) or failure in the intervention arm to actually achieve the individualized CI targets (due to physiological limits or reluctance to push high-dose inotropes) are major threats to validity. A reviewer must scrutinize the 'hemodynamic separation' data to ensure the two groups actually received distinctly different physiological therapies.
Current ERAS and ASA guidelines recommend goal-directed fluid therapy (GDFT) using dynamic parameters to optimize stroke volume, but do not mandate specific cardiac index targets. How does this null result influence the strength of recommendations regarding advanced CI-guided monitoring?
Key Response
This study provides high-quality evidence that reinforces current guidelines, demonstrating that adding individualized absolute CI targets to standard care does not confer additional clinical benefit. Guideline committees should use this to maintain a strong recommendation for dynamic GDFT while explicitly recommending against the routine use of individualized CI-targeted protocols to reduce unnecessary interventions and healthcare costs.
Clinical Landscape
Noteworthy Related Trials
OPTIMISE Trial
Tested
Cardiac output-guided hemodynamic therapy using IV fluid and dopexamine
Population
High-risk patients undergoing major gastrointestinal surgery
Comparator
Usual care
Endpoint
Composite of 30-day moderate or major complications and mortality
RELIEF Trial
Tested
Restrictive perioperative intravenous-fluid regimen
Population
Adults at increased risk for complications undergoing major abdominal surgery
Comparator
Liberal intravenous-fluid regimen
Endpoint
Disability-free survival at 1 year
FEDORA Trial
Tested
Goal-directed hemodynamic therapy guided by esophageal Doppler
Population
Patients undergoing major elective non-cardiac surgery
Comparator
Traditional fluid management
Endpoint
Moderate or severe postoperative complications within 180 days
Tailored to your role
Want this tailored to you?
Add your specialty or training stage to get role-specific takeaways and more questions.
Personalize this analysis